Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 29, 2017

DrugPatentWatch Database Preview

Famotidine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for famotidine and what is the scope of famotidine patent protection?

Famotidine
is the generic ingredient in eleven branded drugs marketed by Perrigo, J And J Consumer Inc, Sandoz, Mylan, Watson Labs, Hospira, Carlsbad, Apothecon, Fresenius Kabi Usa, Merck, Apotex, Ivax Sub Teva Pharms, Teva, Ucb Inc, Alembic Pharms Ltd, Dr Reddys Labs Ltd, Navinta Llc, Athenex Inc, Apotex Inc, Salix Pharms, Abbvie, Aurobindo Pharma Ltd, Wockhardt, Sun Pharm Inds, Lupin Ltd, Mylan Labs Ltd, Merck Sharp Dohme, Actavis Elizabeth, Perrigo R And D, Mylan Pharms Inc, Valeant Pharms North, Sun Pharm Inds Ltd, West-ward Pharms Int, Eurohlth Intl Sarl, Baxter Hlthcare, Hi-tech Pharma Co, Novel Labs Inc, and Horizon Pharma, and is included in sixty-nine NDAs. There are ten patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Famotidine has thirteen patent family members in nine countries.

There are eighteen drug master file entries for famotidine. One hundred and twenty-two suppliers are listed for this compound. There are five tentative approvals for this compound.

Summary for Generic Name: famotidine

Tradenames:11
Patents:10
Applicants:38
NDAs:69
Drug Master File Entries: see list18
Suppliers / Packagers: see list122
Bulk Api Vendors: see list47
Clinical Trials: see list23
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:famotidine at DailyMed

Pharmacology for Ingredient: famotidine

Tentative approvals for FAMOTIDINE

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe10MG/MLInjectable; Injection
► Subscribe► Subscribe10MG/MLInjectable; Injection
► Subscribe► Subscribe10MG/MLInjectable; Injection
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz
FAMOTIDINE
famotidine
TABLET;ORAL075607-001May 10, 2001DISCNNoNo► Subscribe► Subscribe
Eurohlth Intl Sarl
FAMOTIDINE
famotidine
INJECTABLE;INJECTION075799-001Apr 30, 2002DISCNNoNo► Subscribe► Subscribe
Apotex Inc
FAMOTIDINE PRESERVATIVE FREE (PHARMACY BULK)
famotidine
INJECTABLE;INJECTION076322-001Nov 27, 2002DISCNNoNo► Subscribe► Subscribe
Watson Labs
FAMOTIDINE
famotidine
TABLET;ORAL075404-001Nov 28, 2001DISCNNoNo► Subscribe► Subscribe
Merck
PEPCID RPD
famotidine
TABLET, ORALLY DISINTEGRATING;ORAL020752-002May 28, 1998DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Formulary management
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot